University of Granada   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Granada Spain (1531)

Organization Overview

First Clinical Trial
2008
NCT01947426
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Antonia Maria Ruiz Moreno | Complejo Hospitalario Universitario de Granada | COMPLEJO HOSPITALARIO UNIVERSITARIO GRANADA | Consuelo Lourdes Díaz Rodríguez | Department of Nursing, University of Granada, Granada, Spain | Department of Physiotherapy. Faculty of Health Sciences, University of Granada | Gynecology Service of Virgen de las Nieves Hospital, Granada (Spain) | Hospital de San Rafael, Granada | Hospital de San Rafael, Granada (Spain) | Hospital Virgen de las Nieves (Granada) | Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades, Proyectos I+D+i (FEDER 2018, ref. B.CTS.377.UGR18) | Manuel Castillo Garzón | Pharmaceutical Care Research Group | Physical Therapy Deparment, Faculty of Health Sciences, University of Granada | Professor of Gynecology at the Faculty of Medicine of the University of Granada | Specialist in Pediatrics of the Medical-Surgical UGC of Infancy of the University Hospital Complex of Granada (Spain) | Universidad de Granada | University of Granada (Spain) | Virgen de las Nieves Hospital, Granada

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Colic (Phase 2)

Fatty Liver (Phase 2)

Fibromyalgia (Phase 4)

Head and Neck Neoplasms (Phase 2)

Infertility (Phase 3)

Infertility, Female (Phase 1)

Inflammation (Phase 3)

Influenza, Human (Phase 2)

Insulin Resistance (Phase 2)

Liver Diseases (Phase 2)

Metabolic Syndrome (Phase 2)

Morton Neuroma (Phase 4)

Myofascial Pain Syndromes (Phase 4)

Neuroma (Phase 4)

Peri-Implantitis (Phase 4)

Polycystic Ovary Syndrome (Phase 3)

Premature Birth (Phase 3)

Syndrome (Phase 3)

Vitamin B 12 Deficiency (Phase 4)

Vitamin D Deficiency (Phase 3)

Xerostomia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 41
  • # of Trial APIs: 44